Back to PE Pentwater Capital Management LP

ESPRESPR
26 quarters

Position history for PEPentwater Capital Management LP's holdings in ESPERION THERAPEUTICS INC NE

Pentwater Capital Management LP previously held 0 shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$99.4M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$3.69
0
2025-Q3
Unchanged
181,290
0.0%
$480,4190.0%$2.64
0
2025-Q2
Unchanged
181,290
0.0%
$178,4620.0%$0.99
0
2025-Q1
Unchanged
181,290
0.0%
$261,0580.0%$1.50
0
2024-Q4
Unchanged
181,290
0.0%
$398,8380.0%$2.15
0
2024-Q3
Unchanged
181,290
0.0%
$299,1290.0%$1.68
0
2024-Q2
New
181,290
-
$402,4640.0%$2.22
33
2023-Q3
Exited
0
-100.0%
$00.0%$0.98
0
2023-Q2
Unchanged
181,290
0.0%
$251,9930.0%$1.34
0
2023-Q1
Increased
181,290
+29.4%
$288,2510.0%$1.67
29
2022-Q4
Decreased
140,127
-45.1%
$872,9910.0%$6.23
0
2022-Q3
Decreased
255,092
-21.2%
$1.7M0.0%$6.84
0
2022-Q2
Decreased
323,702
-9.6%
$2.1M0.0%$6.67
0
2022-Q1
Decreased
358,006
-1.3%
$1.7M0.0%$4.89
0
2021-Q4
New
362,580
-
$1.8M0.0%$4.96
36
2021-Q3
Exited
0
-100.0%
$00.0%$12.44
0
2021-Q2
Decreased
289,183
-52.4%
$6.1M0.1%$21.13
0
2021-Q1
Increased
607,580
+22.1%
$17M0.2%$27.44
41
2020-Q4
Decreased
497,580
-77.1%
$12.9M0.2%$28.15
0
2020-Q3
Decreased
2.2M
-3.3%
$80.6M1.0%$37.46
0
2020-Q2
Decreased
2.2M
-3.0%
$115.1M2.0%$47.64
0
2020-Q1
Increased
2.3M
+2.6%
$72.9M1.2%$33.98
48
2019-Q4
Decreased
2.3M
-9.1%
$134.4M2.2%$59.82
0
2019-Q3
Increased
2.5M
+1.8%
$90.9M1.4%$37.78
48
2019-Q2
Decreased
2.4M
-1.7%
$113.3M1.2%$46.52
0
2019-Q1
New
2.5M
-
$99.4M1.3%$40.15
68

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used